ID   Nthy-ori 3-1
AC   CVCL_2659
SY   Nthy ori 3.1; Nthy-ori 3.1; NTHY-ORI3.1; HTori-3.1
DR   BTO; BTO:0004859
DR   CLO; CLO_0008209
DR   EFO; EFO_0022713
DR   CLDB; cl3741
DR   cancercelllines; CVCL_2659
DR   ECACC; 90011609
DR   GEO; GSM827409
DR   Progenetix; CVCL_2659
DR   Ubigene; YC-C089
DR   Wikidata; Q54931115
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=22087789;
RX   PubMed=30737244;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
ST   Source(s): ECACC=90011609; PubMed=21868764; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 7,12
ST   D8S1179: 12
ST   FGA: 21,22
ST   TH01: 7 (ECACC=90011609; PubMed=21868764)
ST   TH01: 7,9.3 (PubMed=30737244)
ST   TPOX: 9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4W02 ! HTori-3
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 19
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).
//
RX   PubMed=22087789; DOI=10.1186/1755-8166-4-26; PMCID=PMC3248874;
RA   Maric I., Viaggi S., Caria P., Frau D.V., Degan P., Vanni R.;
RT   "Centrosomal and mitotic abnormalities in cell lines derived from
RT   papillary thyroid cancer harboring specific gene alterations.";
RL   Mol. Cytogenet. 4:26.1-26.8(2011).
//
RX   PubMed=30737244; DOI=10.1158/1078-0432.CCR-18-2953; PMCID=PMC6522280;
RA   Landa I., Pozdeyev N., Korch C.T., Marlow L.A., Smallridge R.C.,
RA   Copland J.A. 3rd, Henderson Y.C., Lai S.Y., Clayman G.L., Onoda N.,
RA   Tan A.-C., Garcia-Rendueles M.E.R., Knauf J.A., Haugen B.R.,
RA   Fagin J.A., Schweppe R.E.;
RT   "Comprehensive genetic characterization of human thyroid cancer cell
RT   lines: a validated panel for preclinical studies.";
RL   Clin. Cancer Res. 25:3141-3151(2019).
//